DexCom (US.DXCM)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.DXCM · YoY: 2026 H1 vs 2025 H1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 79.7% | ↑ |
| ROE | 17.1% | ↑ |
| Cash Conversion | 177.2% | → |
| D/E Ratio | 0.53 | ↑ |
| Gross Margin | 63.2% | ↑ |
US.DXCM (DexCom) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY ---------------------------- FCF Conversion 79.7% ↑ ROE 17.1% ↑ Cash Conversion 177.2% → D/E Ratio 0.53 ↑ Gross Margin 63.2% ↑
Key Metrics
US.DXCM (DexCom) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY----------------------------FCF Conversion 79.7% ↑ROE 17.1% ↑Cash Conversion 177.2% →D/E Ratio 0.53 ↑Gross Margin 63.2% ↑Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies